the flaw in your thinking is that you think you get a typical multiple for what amounts to lawsuit revenue stream. Unless there is a product to be sold with growth potential the market will not reward cash from lawsuits with a multiple.
Proof is in PTSC that has licensed over 60 companies in the past 3-4 yrs for i believe over 100M and there they sit at a PPS worth only their cash ....... or even lower.
No products, no multiple.
jmo.......
biomedman
